{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T08:44:25Z","timestamp":1771922665135,"version":"3.50.1"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p>\n                    Cancer progression involves dynamic crosstalk between tumor-intrinsic pathways and microenvironmental remodeling, and identifying pan-cancer biomarkers is critical for precision oncology.\n                    <jats:italic>CDKN2AIPNL<\/jats:italic>\n                    exhibits a paradoxical role in cancer, acting as a tumor suppressor in myeloid malignancies but promoting solid tumor progression, yet its systematic pan-cancer characteristics remain unelucidated. This study aimed to comprehensively analyze\n                    <jats:italic>CDKN2AIPNL\u2019s<\/jats:italic>\n                    expression patterns, prognostic value, genetic alterations, and molecular mechanisms across multiple tumor types using public datasets including TCGA, GTEx, HPA, and tools such as GEPIA2, cBioPortal, TIMER2, STRING, and BioGRID. We performed expression difference analysis, survival analysis (overall survival, disease-free survival, progression-free survival), genetic alteration analysis, cancer-associated fibroblast (CAF) infiltration analysis, and gene\/protein interaction enrichment analysis. Results showed that CDKN2AIPNL was significantly upregulated in multiple tumors (e.g., LIHC, UVM, BRCA, LUAD) and downregulated in others (e.g., KICH, KIRP, THCA), with high tumor specificity. Elevated CDKN2AIPNL expression correlated with poor overall survival in LIHC (HR = 1.7, p = 0.0026), UVM (HR = 26, p = 2.2e-6), BRCA (HR = 26, p = 2.2e-6), LUAD (HR = 1.36, p = 0.049), PCPG (HR = 1.71, p = 0.0012), and TGCT (HR = 0.37, p=0.023), and was associated with advanced tumor stages in metabolically active cancers. Genetic alterations (amplifications and mutations) were frequent in KIRC (&amp;gt;5%) and ACC (&amp;gt;4%), with all mutations localized to the XTBD region, and amplification predicted poor prognosis in PRAD (p = 0.008) while mutations conferred favorable outcomes in BLCA. CDKN2AIPNL expression positively correlated with CAF infiltration in ESCA, KICH, UVM, and other tumors, and interacted with MYC, XRN2, and CHAMP1 to regulate metabolic reprogramming, cell cycle, and immune suppression. Our findings systematically reveal CDKN2AIPNL\u2019s dual role in tumorigenesis and validate it as a potential pan-cancer prognostic biomarker, providing novel insights for cancer diagnosis and targeted therapy.\n                  <\/jats:p>","DOI":"10.3389\/fgene.2025.1588292","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T22:10:21Z","timestamp":1768947021000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["CDKN2AIPNL: a potential pan-cancer biomarker"],"prefix":"10.3389","volume":"16","author":[{"given":"Yulin","family":"Yuan","sequence":"first","affiliation":[{"name":"Maoming Hospital of Traditional Chinese Medicine","place":["Maoming, Guangdong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Xiao","family":"Ma","sequence":"additional","affiliation":[{"name":"Maoming Hospital of Traditional Chinese Medicine","place":["Maoming, Guangdong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heshi","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Gastrocolorectal Surgery, The First Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Gong","sequence":"additional","affiliation":[{"name":"Department of Gastrocolorectal Surgery, The First Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Gastrocolorectal Surgery, The First Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Gastrocolorectal Surgery, The First Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weifu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gastrocolorectal Surgery, The First Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.1158\/1078-0432.CCR-21-0575","article-title":"CDKN2A alterations and response to immunotherapy in solid tumors","volume":"27","author":"Adib","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1042\/BCJ20190733","article-title":"Full-length NF-\u03baB repressing factor contains an XRN2 binding domain","volume":"477","author":"Alexandrova","year":"2020","journal-title":"Biochem. J."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1111\/exd.14814","article-title":"Proteomic profiling of cutaneous melanoma explains the aggressiveness of distant organ metastasis","volume":"32","author":"Azimi","year":"2023","journal-title":"Exp. Dermatol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1038\/s41590-024-01945-3","article-title":"An atlas of genetic effects on cellular composition of the tumor microenvironment","volume":"25","author":"Cai","year":"2024","journal-title":"Nat. Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13578-022-00861-z","article-title":"CDKN2AIP is critical for spermiogenesis and germ cell development","volume":"12","author":"Cao","year":"2022","journal-title":"Cell Biosci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40170-021-00270-9","article-title":"Targeting MYC-enhanced glycolysis for the treatment of small cell lung cancer","volume":"9","author":"Cargill","year":"2021","journal-title":"Cancer Metab."},{"key":"B7","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.tig.2020.10.005","article-title":"Germline variants that affect tumor progression","volume":"37","author":"Chatrath","year":"2021","journal-title":"Trends Genet."},{"key":"B8","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","article-title":"Turning foes to friends: targeting cancer-associated fibroblasts","volume":"18","author":"Chen","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"B9","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s41571-021-00546-5","article-title":"Clinical and therapeutic relevance of cancer-associated fibroblasts","volume":"18","author":"Chen","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1038\/s41598-022-06934-w","article-title":"Weighted correlation network analysis revealed novel long non-coding RNAs for colorectal cancer","volume":"12","author":"Chodary Khameneh","year":"2022","journal-title":"Sci. Rep."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/s41418-024-01324-3","article-title":"A novel MYC-ZNF706-SLC7A11 regulatory circuit contributes to cancer progression and redox balance in human hepatocellular carcinoma","volume":"31","author":"Chu","year":"2024","journal-title":"Cell Death Differ."},{"key":"B12","doi-asserted-by":"publisher","first-page":"7073","DOI":"10.1038\/s41598-020-63759-1","article-title":"Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes","volume":"10","author":"De Talhouet","year":"2020","journal-title":"Sci. Rep."},{"key":"B13","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1074\/mcp.M113.035600","article-title":"Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics","volume":"13","author":"Fagerberg","year":"2014","journal-title":"Mol. Cell Proteomics"},{"key":"B14","doi-asserted-by":"publisher","first-page":"7400","DOI":"10.3390\/ijms25137400","article-title":"TGF-\u03b2 modulated pathways in colorectal cancer: new potential therapeutic opportunities","volume":"25","author":"Fasano","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1038\/s41388-022-02299-6","article-title":"CHAMP1-POGZ counteracts the inhibitory effect of 53BP1 on homologous recombination and affects PARP inhibitor resistance","volume":"41","author":"Fujita","year":"2022","journal-title":"Oncogene"},{"key":"B16","doi-asserted-by":"publisher","first-page":"3438","DOI":"10.1016\/j.molcel.2022.08.012","article-title":"Structure of the RAF1-HSP90-CDC37 complex reveals the basis of RAF1 regulation","volume":"82","author":"Garc\u00eda-Alonso","year":"2022","journal-title":"Mol. Cell"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1101\/gr.2596504","article-title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)","volume":"14","author":"Gerhard","year":"2004","journal-title":"Genome Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13000-023-01401-0","article-title":"DNA damage response and repair gene mutations are associated with tumor mutational burden and outcomes to platinum-based chemotherapy\/immunotherapy in advanced NSCLC patients","volume":"18","author":"Gu","year":"2023","journal-title":"Diagn Pathol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"3711","DOI":"10.1111\/cas.15018","article-title":"Chromosome alignment-maintaining phosphoprotein CHAMP1 plays a role in cell survival through regulating Mcl-1 expression","volume":"112","author":"Hino","year":"2021","journal-title":"Cancer Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT signaling pathway: from bench to clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"key":"B21","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3233\/CBM-210340","article-title":"Clinical powers of aminoacyl tRNA synthetase complex interacting multifunctional protein 1 (AIMP1) for head-neck squamous cell carcinoma","volume":"34","author":"Li","year":"2022","journal-title":"Cancer Biomark."},{"key":"B22","doi-asserted-by":"publisher","first-page":"111297","DOI":"10.1016\/j.celrep.2022.111297","article-title":"CHAMP1 binds to REV7\/FANCV and promotes homologous recombination repair","volume":"40","author":"Li","year":"2022","journal-title":"Cell Rep."},{"key":"B23","doi-asserted-by":"publisher","first-page":"216877","DOI":"10.1016\/j.canlet.2024.216877","article-title":"PRMT5 activates lipid metabolic reprogramming via MYC contributing to the growth and survival of mantle cell lymphoma","volume":"591","author":"Liang","year":"2024","journal-title":"Cancer Lett."},{"key":"B24","doi-asserted-by":"publisher","first-page":"3244","DOI":"10.3892\/or.2019.7091","article-title":"Gene profiling of HepG2 cells following nitidine chloride treatment: an investigation with microarray and connectivity mapping","volume":"41","author":"Liu","year":"2019","journal-title":"Oncol. Rep."},{"key":"B25","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s10142-024-01443-7","article-title":"Is the voltage-gated sodium channel \u03b23 subunit (SCN3B) a biomarker for glioma?","volume":"24","author":"Liu","year":"","journal-title":"Funct. Integr. Genomics"},{"key":"B26","doi-asserted-by":"publisher","first-page":"19142","DOI":"10.1038\/s41598-024-70184-1","article-title":"Identification of the novel exhausted T cell CD8 + markers in breast cancer","volume":"14","author":"Liu","year":"","journal-title":"Sci. Rep."},{"key":"B27","doi-asserted-by":"publisher","first-page":"102042","DOI":"10.1016\/j.genrep.2024.102042","article-title":"Genetic expression in cancer research: challenges and complexity","volume":"37","author":"Liu","year":"","journal-title":"Gene Rep."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20211103","article-title":"CDKN2A is a prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma","volume":"41","author":"Luo","year":"2021","journal-title":"Biosci. Rep."},{"key":"B29","doi-asserted-by":"publisher","first-page":"4708076","DOI":"10.1155\/2017\/4708076","article-title":"The role of PDGFs and PDGFRs in colorectal cancer","volume":"2017","author":"Manzat Saplacan","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2516865718814543","DOI":"10.1177\/2516865718814543","article-title":"Identification of deregulated signaling pathways in jurkat cells in response to a novel acylspermidine analogue-N(4)-erucoyl spermidine","volume":"11","author":"Razvi","year":"2018","journal-title":"Epigenet Insights"},{"key":"B31","doi-asserted-by":"publisher","first-page":"834235","DOI":"10.3389\/fonc.2022.834235","article-title":"The cell cycle-associated protein CDKN2A may promotes colorectal cancer cell metastasis by inducing epithelial-mesenchymal transition","volume":"12","author":"Shi","year":"2022","journal-title":"Front. Oncol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"B33","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cancergen.2024.06.002","article-title":"Cancer treatments: past, present, and future","author":"Sonkin","year":"2024","journal-title":"Cancer Genet."},{"key":"B34","doi-asserted-by":"publisher","first-page":"175087","DOI":"10.1016\/j.ejphar.2022.175087","article-title":"Cancer-associated fibroblasts (CAFs) and tumor-associated macrophages (TAMs); where do they stand in tumorigenesis and how they can change the face of cancer therapy?","volume":"928","author":"Tajaldini","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/leu.2016.295","article-title":"Complete mutational spectrum of the autophagy interactome: a novel class of tumor suppressor genes in myeloid neoplasms","volume":"31","author":"Visconte","year":"2017","journal-title":"Leukemia"},{"key":"B36","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","article-title":"A guide to cancer immunotherapy: from T cell basic science to clinical practice","volume":"20","author":"Waldman","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s11033-024-09247-5","article-title":"CDKN2A promoter methylation enhances self-renewal of glioblastoma stem cells and confers resistance to carmustine","volume":"51","author":"Wang","year":"2024","journal-title":"Mol. Biol. Rep."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.cmet.2023.07.006","article-title":"Emerging therapies in cancer metabolism","volume":"35","author":"Xiao","year":"2023","journal-title":"Cell Metab."},{"key":"B39","doi-asserted-by":"publisher","first-page":"15747","DOI":"10.1007\/s00210-025-04246-0","article-title":"The m6 A modification of CDKN2 A inhibites ferroptosis and affects the resistance of cervical squamous cell carcinoma to cisplatin","volume":"398","author":"Yong","year":"2025","journal-title":"Naunyn Schmiedeb. Arch. Pharmacol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41419-024-06721-7","article-title":"The cell cycle regulator p16 promotes tumor infiltrated CD8+ T cell exhaustion and apoptosis","volume":"15","author":"Zhang","year":"2024","journal-title":"Cell Death Dis."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2025.1588292\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T07:39:03Z","timestamp":1771918743000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2025.1588292\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":40,"alternative-id":["10.3389\/fgene.2025.1588292"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2025.1588292","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"article-number":"1588292"}}